HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcome

BACKGROUND: An association between tumor-specific HMG-CoA reductase (HMGCR) expression and good prognosis has previously been demonstrated in breast and ovarian cancer. In this study, the expression, clinicopathological correlates and prognostic value of HMGCR expression in colorectal cancer was exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bengtsson, Erik, Nerjovaj, Pashtrik, Wangefjord, Sakarias, Nodin, Björn, Eberhard, Jakob, Uhlén, Mathias, Borgquist, Signe, Jirström, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000148/
https://www.ncbi.nlm.nih.gov/pubmed/24708688
http://dx.doi.org/10.1186/1746-1596-9-78

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000148/
https://www.ncbi.nlm.nih.gov/pubmed/24708688
http://dx.doi.org/10.1186/1746-1596-9-78

Ejemplares similares